Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- By Product
5.1 Introduction
5.2 Neurostimulation and Neuromodulation Devices
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Biomaterials
5.3.1 Market Overview
5.3.2 Market Size and Forecast
- By Application
6.1 Introduction
6.2 Neurostimulation and Neuromodulation Surgeries
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Direct Nerve Repair/Neurorrhaphy
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Nerve Grafting
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Stem Cell Therapy
6.5.1 Market Overview
6.5.2 Market Size and Forecast
- By End-User
7.1 Introduction
7.2 Hospitals & Clinics
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Ambulatory Surgery Centers
7.3.1 Market Overview
7.3.2 Market Size and Forecast
- By Geography
8.1 Introduction
8.2 Europe
8.2.1 Europe Market, By Product
8.2.2 Europe Market, By Application
8.2.3 Europe Market, By End User
8.3 North America
8.3.1 North America Market, By Product
8.3.2 North America Market, By Application
8.3.3 North America Market, By End User
8.4 Asia Pacific
8.4.1 Asia Pacific Market, By Product
8.4.2 Asia Pacific Market, By Application
8.4.3 Asia Pacific Market, By End User
8.5 Rest of The World
8.5.1 Rest of The World Market, By Product
8.5.2 Rest of The World Market, By Application
8.5.3 Rest of The World Market, By End User
- Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
- Company Profiles
(Overview, Key Financials, Product and Service Offering, Recent Developments)
- Medtronic
- Abbott Laboratories
- Stryker
- Polyganics
- Nuvectra
- Neuropace
- Orthomed
- Nevro
- Axogen
- Baxter
- Boston Scientific
- Livanova
- Integra Lifesciences